NOT KNOWN FACTUAL STATEMENTS ABOUT SITUS JUDI MBL77

Not all sufferers with CLL demand therapy. Irrespective of all current advancements, the iwCLL however suggests watchful observation for people with asymptomatic sickness.86 This recommendation relies on a minimum of two randomized trials evaluating observation to either chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).